These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32804335)

  • 1. Mechanisms Involved in Superiority of Angiotensin Receptor Blockade over ACE Inhibition in Attenuating Neuropathic Pain Induced in Rats.
    Hegazy N; Rezq S; Fahmy A
    Neurotherapeutics; 2020 Jul; 17(3):1031-1047. PubMed ID: 32804335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin system blockade modulates both the peripheral and central components of neuropathic pain in rats: Role of calcitonin gene-related peptide, substance P and nitric oxide.
    Hegazy N; Rezq S; Fahmy A
    Basic Clin Pharmacol Toxicol; 2020 Dec; 127(6):451-460. PubMed ID: 32542932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan and captopril ameliorate pregabalin-induced heart failure in rats.
    Awwad ZM; El-Ganainy SO; ElMallah AI; Khattab MM; El-Khatib AS
    Toxicology; 2019 Dec; 428():152310. PubMed ID: 31629013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin Receptor Blockade Modulates NFκB and STAT3 Signaling and Inhibits Glial Activation and Neuroinflammation Better than Angiotensin-Converting Enzyme Inhibition.
    Bhat SA; Goel R; Shukla R; Hanif K
    Mol Neurobiol; 2016 Dec; 53(10):6950-6967. PubMed ID: 26666666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
    Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
    Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ameliorative potential of angiotensin-converting enzyme inhibitor (ramipril) on chronic constriction injury of sciatic nerve induced neuropathic pain in mice.
    Kaur P; Muthuraman A; Kaur J
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):103-12. PubMed ID: 25487978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?
    Werner C; Pöss J; Böhm M
    Drugs; 2010 Jul; 70(10):1215-30. PubMed ID: 20568830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin Angiotensin Blockers and Cardiac Protection: From Basis to Clinical Trials.
    Lévy BI; Mourad JJ
    Am J Hypertens; 2022 Apr; 35(4):293-302. PubMed ID: 34265036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition.
    Juhlin T; Erhardt LR; Ottosson H; Jönsson BA; Höglund P
    Eur J Heart Fail; 2007 Feb; 9(2):191-6. PubMed ID: 16859993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy.
    Pathak JV; Dass EE
    Indian J Pharmacol; 2015; 47(2):148-52. PubMed ID: 25878372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE-inhibition and angiotensin II receptor blockers in chronic heart failure: pathophysiological consideration of the unresolved battle.
    Simko F; Simko J; Fabryova M
    Cardiovasc Drugs Ther; 2003 May; 17(3):287-90. PubMed ID: 14669746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G; Amiri F; Garcia R
    Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.
    Schindler C
    Ther Adv Cardiovasc Dis; 2008 Aug; 2(4):233-48. PubMed ID: 19124424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of losartan, an angiotensin II receptor antagonist, in animal models of hypertension.
    Siegl PK; Kivlighn SD; Broten TP
    J Hypertens Suppl; 1995 Jul; 13(1):S15-21. PubMed ID: 18800451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preclinical basis of the therapeutic evaluation of losartan.
    Timmermans PB; Wong PC; Chiu AT; Smith RD
    J Hypertens Suppl; 1995 Jul; 13(1):S1-13. PubMed ID: 18800450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of angiotensin inhibition.
    Nobakht N; Kamgar M; Rastogi A; Schrier RW
    Nat Rev Nephrol; 2011 Jun; 7(6):356-9. PubMed ID: 21502972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
    Aulakh GK; Sodhi RK; Singh M
    Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin system blockade at the level of the angiotensin converting enzyme or the angiotensin type-1 receptor: similarities and differences.
    Stergiou GS; Skeva II
    Curr Top Med Chem; 2004; 4(4):473-81. PubMed ID: 14965313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.